Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ascendis Pharma Ads (NQ: ASND )

157.46 USD -4.55 (-2.81%)
Streaming Delayed Price Updated: 2:49 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Ascendis Pharma Ads

< Previous 1 2 3 4 5 6 7 8 9 Next >
Visen Pharma Closes $150 Million Financing for Endocrine Drugs
Shanghai 's Visen Pharma closed a $150 million Series B financing to develop novel endocrine drugs in a round led by Sequoia China . In 2018, Visen was formed by Ascendis Pharma A/S of Denmark and an... 
From ChinaBio® Today
A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Final Trading Session Of 2020
Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade on the last trading day of 2020. Markets closed ... 
Tags TIF ENPH FCPT
From Benzinga
5 Stocks To Watch For December 31, 2020
Some of the stocks that may grab investor focus today are: S&P Dow Jones Indices reported that Enphase Energy Inc. (NASDAQ: ... 
Tags Stocks to Watch ASND Stocks To Watch
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 17, 2020
Upgrades For CAE Inc (NYSE:CAE), Bank of America upgraded the previous rating of Neutral to Buy. CAE earned $0.10 in the ... 
Tags WES QSR TCF
From Benzinga
The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags PRAX AGIO Small Cap
From Benzinga
Stocks That Hit 52-Week Highs On Monday
Monday's morning session saw 240 companies set new 52-week highs. Key Facts: The largest company by market cap to ... 
Tags TJX LPRO RNG
From Benzinga
Stocks That Hit 52-Week Highs On Friday
This morning 167 companies reached new 52-week highs. Noteables: Walt Disney (NYSE: DIS) was the largest firm on a ... 
Tags FTDR WAL BG
From Benzinga
Ascendis Pharma Earns Relative Strength Rating Upgrade
Ascendis Pharma shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
10 Biggest Price Target Changes For Friday
Raymond James raised the price target for Costco Wholesale Corporation (NASDAQ: COST) from $365 to $405. Costco shares rose 0.1% to ... 
Tags Price Target Changes Analyst Ratings PDD
From Benzinga
Recap: Ascendis Pharma Q3 Earnings
Shares of Ascendis Pharma (NASDAQ:ASND) were flat in after-market trading after the company reported Q3 results. Quarterly ... 
Tags ASND Benzinga Earnings
From Benzinga
The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ASND RHHBY ORIC
From Benzinga
Earnings Scheduled For November 11, 2020
Companies Reporting Before The Bell • Air Products & Chemicals (NYSE:APD) is projected to report quarterly ... 
Tags SPTN Intraday Update PYPD
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags bluebird bio inc/ MRSN ASND
From Benzinga
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags RGEN ADAP AZN
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
This morning 118 companies reached new 52-week highs. Noteworthy Points: Alphabet (NASDAQ: GOOG) was the company with ... 
Tags IDRA UNH DLB
From Benzinga
The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags TARO BIO NVS
From Benzinga
The Daily Biotech Pulse: Pfizer, BioNTech Begin European Filing For Coronavirus Vaccine, Y-mAbs BLA Rejected, GlycoMimetics Granted Rare Pediatric Disease Designation
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags PFE RGEN MGEN
From Benzinga
Stocks That Hit 52-Week Highs On Monday
During Monday's morning session, 149 companies made new 52-week highs. Interesting Facts: Unilever (NYSE: UL) was ... 
Tags MHO DPZ CARR
From Benzinga
Stocks That Hit 52-Week Highs On Friday
On Friday morning, 60 companies achieved new highs for the year. Intriguing Points: ServiceNow (NYSE: NOW) was the ... 
Tags Materials CSTL VRT
From Benzinga
The Daily Biotech Pulse: FDA Nod For Pfizer, Sorrento's COVID-19 Antibody Animal Data, Orphazyme's Wall Street Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ANPC T TCDA
From Benzinga
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
Biotech stock reversed course lastweek, dragged lower by the broader market weakness. The week's news flow was headlined by ... 
Tags MRNA MGTX Penny Stocks
From Benzinga
Stocks Showing Rising Market Leadership: Ascendis Pharma Earns 82 RS Rating
Ascendis Pharma shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 82. 
From Investor's Business Daily
The Daily Biotech Pulse: Gilead's $7.25B Debt Offering, Lexicon Deleverages, Taysha Gene Therapies Prices IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags HZNP AYTU RNLX
From Benzinga
Ascendis Pharma Shows Rising Relative Price Performance; Still Shy Of Key Benchmark
A Relative Strength Rating upgrade for Ascendis Pharma shows improving technical performance. Will it continue? 
From Investor's Business Daily
Ascendis Pharma Reaches 80-Plus Relative Strength Rating Benchmark
A Relative Strength Rating upgrade for Ascendis Pharma shows improving technical performance. 
From Investor's Business Daily
Stocks Showing Rising Market Leadership: Ascendis Pharma Earns 82 RS Rating
Ascendis Pharma sees its Relative Strength Rating reach the 80-plus level. 
From Investor's Business Daily
Ascendis Pharma Getting Closer To Key Technical Benchmark
Ascendis Pharma shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Ascendis Pharma A/S (ASND) Q2 2020 Earnings Call Transcript
ASND earnings call for the period ending June 30, 2020. 
Tags ASND Market News
From Motley Fool
Ascendis Pharma: Q2 Earnings Insights
Shares of Ascendis Pharma (NASDAQ:ASND) were unchangedafter the company reported Q2 results. Quarterly Results Earnings per ... 
Tags Market News Earnings Benzinga
From Benzinga
The Daily Biotech Pulse: Liver Congress Underway, FDA Approves Companion Diagnostic Test For Clovis Cancer Drug, EUA For Abbott's $5, 15-Minute COVID-19 Test
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) 10X Genomics Inc (NASDAQ: TXG) Abbott Laboratories (NYSE: ... 
Tags ADXN NARI MIRM
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.